Study of Cerebral Function in Patients With Chronic Hepatitis C Infection Before and After Pegylated Interferon Alfa-2a and Ribavirin Therapy.
Phase of Trial: Phase IV
Latest Information Update: 10 Jan 2013
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Pharmacodynamics
- 01 Nov 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Mar 2012 Actual initiation date changed from 1 Nov 2008 to 7 Aug 2008 as reported by European Clinical Trials Database.
- 19 Dec 2011 Planned end date changed from 1 Aug 2012 to 1 Aug 2013 as reported by ClinicalTrials.gov.